Which company is leading CRISPR?
I want to know which company is at the forefront of CRISPR technology, possibly in terms of research, development, or application.
Will CRISPR make money?
I'm wondering if investing in CRISPR will be profitable. With the advancements in gene editing technology, I'm curious to know if CRISPR has the potential to generate significant returns.
How much is a share of Crispr?
I am interested in investing in Crispr and would like to know the current price of a share. Can someone please tell me how much a share of Crispr costs?
Who holds the patent on CRISPR?
The patent on CRISPR is a subject of complex dispute. Originally, the Broad Institute was granted a key patent on CRISPR-Cas9 gene editing in 2014, specifically for its use in eukaryotic cells. However, the University of California, Berkeley, where Jennifer Doudna and Emmanuelle Charpentier conducted their pivotal research, also filed for a patent. This led to a prolonged legal battle over the ownership of the CRISPR patent. Recently, there has been a surprising development in this dispute, with Doudna and Charpentier's team requesting the cancellation of their own European patents, citing inadequate explanation of CRISPR in their earliest patent applications. This move could potentially impact the commercial landscape of CRISPR technology.
What will CRISPR be worth in 10 years?
Could you please elaborate on your thoughts regarding the potential value of CRISPR technology in the next decade? What factors do you believe will contribute to its growth, and how do you anticipate the market for gene editing tools will evolve? Additionally, are there any potential challenges or limitations that could hinder its widespread adoption and affect its overall worth?